Showing results (361-370 of 494) with videos related to

Sort By:
Pageof 50
Biomedical and Environmental Sciences : BES|July 10, 2023
Benchmark Dose Assessment for Coke Oven Emissions-Induced Mitochondrial DNA Copy Number Damage EffectsZhao Fan Yan, Zhi Guang Gu, Ya Hui Fan, et al.
Drug Design, Development and Therapy|March 2, 2016
A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosisShizhang Wei, Ming Niu, Jian Wang, et al.
Molecular Genetics and Metabolism Reports|April 25, 2025
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapyUma Ramaswami, Guillem Pintos-Morell, Christoph Kampmann, et al.
Pediatric Pulmonology|August 19, 2010
Polysomnographic characteristics in patients with mucopolysaccharidosesHsiang-Yu Lin, Ming-Ren Chen, Ching-Chi Lin, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activationZhilei Wang, Guang Xu, Hongbo Wang, et al.
Electrophoresis|January 13, 2009
Identification of CpG methylation of the SNRPN gene by methylation-specific multiplex PCRChia-Cheng Hung, Shin-Yu Lin, Shuan-Pei Lin, et al.
Medical Physics|January 20, 2022
Physical and imaging performance of SIAT aPET under different energy windows and timing windowsZhonghua Kuang, Xiaohui Wang, Ning Ren, et al.
Molecular Genetics & Genomic Medicine|October 9, 2018
The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidosesHsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, et al.
The Canadian Journal of Cardiology|March 9, 2025
Early Potentially Irreversible Cardiac Damage in Fabry Disease Precedes Gb3 Inclusion Body FormationChung-Lin Lee, Pei-Sin Chen, Yu-Ying Lu, et al.
Pageof 50